StockData
Lifecore Biomedical, Inc. logo

Lifecore Biomedical, Inc. (LFCR) stock

LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
Financials through Q4 FY2025, quarter ended May 25, 2025Last filing: 10-Q on Nov 4, 2026Score 4/30
$6.39−0.03 (-0.39%)

Close on Nov 17, 2026Market cap $241.88MP/E –Yield –

Lifecore Biomedical market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Lifecore Biomedical's market cap was $241.26M on Nov 11, 2026, against $295.98M a year earlier. Over the last 5 years it ranged from $114.37M to $341.39M, with a median of $242.58M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$241.26M-21.3%
2025Dec 31, 2025$306.47M+33.5%
2024Dec 31, 2024$229.57M+21.8%
2023Dec 29, 2023$188.52M-1.7%
2022Dec 30, 2022$191.76M-41.4%
2021Dec 31, 2021$327.03M+3.1%
2020Dec 31, 2020$317.28M-3.8%
2019Dec 31, 2019$329.64M+0.3%
2018Dec 31, 2018$328.55M-5.2%
2017Dec 29, 2017$346.59M-7.8%
2016Dec 30, 2016$375.93M+17.6%
2015Dec 31, 2015$319.59M-13.8%
2014Dec 31, 2014$370.73M+15.5%
2013Dec 31, 2013$320.92M+31.3%
2012Dec 31, 2012$244.50M+67.7%
2011Dec 30, 2011$145.79M+91442.4%
2010Dec 31, 2010$159.27K–

More Lifecore Biomedical figures

See a number that looks wrong?